Related Experiment Video

Updated: Jan 9, 2026

Pulmonary Embolism III: Nursing Management
01:27

Pulmonary Embolism III: Nursing Management

Published on: June 19, 2025

320

Aspirin- and coumadin-related bleeding after coronary- artery bypass graft surgery

M Torosian, E L Michelson, J Morganroth

    Annals of Internal Medicine
    |September 1, 1978
    PubMed

    Insights

    Preoperative aspirin and Coumadin significantly increase bleeding after coronary-artery bypass graft surgery. Heparin did not affect blood loss, unlike other antiplatelet agents.

    Area of Science:

    • Cardiology
    • Vascular Surgery
    • Pharmacology

    Background:

    • Platelet active and antithrombotic agents are commonly prescribed.
    • Understanding their impact on bleeding complications is crucial for patient safety.

    Purpose of the Study:

    • To evaluate the effect of preoperative antiplatelet and antithrombotic agents on bleeding after coronary-artery bypass graft (CABG) surgery.

    Main Methods:

    • A study of 100 consecutive patients undergoing CABG surgery.
    • Comparison of mediastinal blood loss and chest tube drainage among patients taking different preoperative medications (aspirin, Coumadin, heparin, other antiplatelet agents) and a control group.

    Main Results:

    • Patients taking aspirin or Coumadin (warfarin sodium) had significantly greater mediastinal blood loss (892 ± 91 ml and 858 ± 168 ml, respectively) compared to controls (439 ± 28 ml).
    • Other platelet-inhibiting agents also showed increased blood loss, though less marked.
    • Heparin use did not result in increased blood loss (436 ± 61 ml).
    • Aspirin and Coumadin users required prolonged chest tube drainage (34 ± 4 h) compared to heparin or control groups (20 ± 1 h).

    Conclusions:

    • Preoperative aspirin and Coumadin are associated with increased bleeding complications and prolonged drainage after CABG surgery.
    • Heparin does not appear to increase postoperative bleeding in this context.
    • Careful consideration of preoperative antithrombotic/antiplatelet therapy is warranted for patients undergoing CABG.

    More Related Videos

    Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

    Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

    Published on: June 19, 2025

    277
    Pulmonary Embolism I: Introduction01:29

    Pulmonary Embolism I: Introduction

    Published on: June 19, 2025

    464

    Related Concept Videos

    Pulmonary Embolism III: Nursing Management01:27

    Pulmonary Embolism III: Nursing Management

    A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
    320
    Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

    Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

    Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
    277
    Pulmonary Embolism I: Introduction01:29

    Pulmonary Embolism I: Introduction

    Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
    464
    Venous Thrombosis III: Interprofessional Care01:29

    Venous Thrombosis III: Interprofessional Care

    Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
    262
    Pneumothorax-II01:27

    Pneumothorax-II

    Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
    Clinical Manifestations:
    852
    Chronic Obstructive Pulmonary Disease-V: Management01:29

    Chronic Obstructive Pulmonary Disease-V: Management

    Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
    Smoking Cessation
    3.1K